Paper - WANFANG MED ONLINE

You Position: Home > Paper

Advances in the Treatment of Rosacea-Associated Facial Erythema

( views:16, downloads:0 )

Author:: No author available

Journal Title:: International Journal of Dermatology and Venereology

Issue:: 3

DOI:: 10.1097/JD9.0000000000000237

Key Word:: rosacea;erythema;treatment;rosacea;erythema;treatment

Abstract： Facial erythema is the main characteristic of rosacea. It has a negative impact on quality of life. The two forms of rosacea-associated erythema are inflammatory erythema and non-inflammatory erythema. There are numerous therapeutic options available that achieve satisfactory responses. This review summarizes the latest advances in the treatment of rosacea-related erythema and concludes the treatment of two forms of them.

Reference

[1]中国医师协会皮肤科医师分会皮肤美容亚专业委员会.中国玫瑰痤疮诊疗专家共识（2016）[J].2017,(3).
[2]Fedorowicz Z,van Zuuren EJ,Kramer SF,etc.Effective and evidence-based management strategies for rosacea: summary of a Cochrane systematic review.[J].2011,165(4).
[3]Shaomin Zhong,Nan Sun,Huixian Liu,etc.Topical tranexamic acid improves the permeability barrier in rosacea[J].2015,33(2).
[4]Bageorgou Fotini,Vasalou Varvara,Tzanetakou Vasiliki,etc.The new therapeutic choice of tranexamic acid solution in treatment of erythematotelangiectatic rosacea[J].2019,18(2).
[5]Joel T.M Bamford,Barbara A Elliott,Irina V Haller.Tacrolimus effect on rosacea[J].2004,50(1).
[6]Park, Kul Young,Hyun, Moo Yeol,Jeong, Se Yeong,etc.Botulinum Toxin for the Treatment of Refractory Erythema and Flushing of Rosacea[J].2015,230(4).
[7]Liu, Jianjun,Liu, Junlian,Ren, Yingyun,etc.Comparative efficacy of intense pulsed light for different erythema associated with rosacea[J].2014,16(6).
[8]Taieb, A.,Khemis, A.,Ruzicka, T.,etc.Maintenance of remission following successful treatment of papulopustular rosacea with ivermectin 1; cream vs. metronidazole 0.75; cream: 36-week extension of the ATTRACT randomized study[J].2016,30(5).
[9]Joel,Schlessinger,Mark,Lupin,David,McDaniel,etc.Safety and Effectiveness of Microfocused Ultrasound for Treating Erythematotelangiectatic Rosacea[J].2019,18(6).
[10]Cho, Eun Byul,Park, Bok Won,Kim, Kwang Ho,etc.Comparison of efficacy between long-pulsed Nd:YAG laser and pulsed dye laser to treat rosacea-associated nasal telangiectasia[J].2018,20(5).
[11]M. C. C. P. Tirico,D. Jensen,C. Green,etc.Short pulse intense pulsed light versus pulsed dye laser for the treatment of facial redness[J].2020,22(2).
[12]丁语,赵海光.聚多卡醇治疗红斑毛细血管扩张型玫瑰痤疮12例疗效观察[J].2020,(3).
[13]Juliandri Juliandri,Wang Xiaoyan,Liu Zijing,etc.Global rosacea treatment guidelines and expert consensus points: The differences[J].2019,18(4).
[14]James Q. Del Rosso.Management of facial erythema of rosacea: What is the role of topical α-adrenergic receptor agonist therapy?[J].2013,69(Supplement 1).
[15]Baldwin Hilary,Santoro Francine,Lachmann Nadege,etc.A novel moisturizer with high sun protection factor improves cutaneous barrier function and the visible appearance of rosacea‐prone skin[J].2019,18(6).
[16]Two, Aimee M.,Gallo, Richard L.,Hata, Tissa R.,etc.Rosacea Part II. Topical and systemic therapies in the treatment of rosacea[J].2015,72(5).
[17]Baskan, Emel Bulbul,Belli, Asli Akin.Evaluation of long-term efficacy, safety, and effect on life quality of pulsed dye laser in rosacea patients[J].2019,21(4).
[18]Kwon, Hyun Jung,Suh, Joon Hyuk,Ko, Eun Jung,etc.Combination treatment of propranolol, minocycline, and tranexamic acid for effective control of rosacea[J].2017,30(3).
[19]Sun, Yan,Chen, Lianghong,Zhang, Yuhui,etc.Topical photodynamic therapy with 5-aminolevulinic acid in Chinese patients with Rosacea[J].2019,21(4).
[20]Schaller, M.,Almeida, L. M. C.,Bewley, A.,etc.Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel[J].2017,176(2).
[21]Friedman Or,Koren Amir,Niv Roni,etc.The toxic edge—A novel treatment for refractory erythema and flushing of rosacea[J].2019,51(4).
[22]刘英姿,谢红付,李吉,等.羟氯喹治疗60例轻中度酒渣鼻的有效性及安全性临床观察[J].2015,(4).
[23]Li, Yangfan,Xie, Hongfu,Deng, Zhili,etc.Tranexamic acid ameliorates rosacea symptoms through regulating immune response and angiogenesis[J].2019,67.
[24]Amanda K,Suggs,Angela,Macri,Heather,Richmond,etc.Treatment of Erythematotelangiectatic Rosacea With Pulsed-Dye Laser and Oxymetazoline 1.0% Cream: A Retrospective Study.[J].2020,52(1).
[25]E.J. Zuuren,Z. Fedorowicz,J. Tan,etc.Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments[J].2019,181(1).
[26]Nwanneka Okwundu,Abigail Cline,Steven R. Feldman.Difference in vasoconstrictors: oxymetazoline vs. brimonidine[J].2021,32(2).
[27]汪犇,赵志祥,简丹,等.中国玫瑰痤疮临床特征分析和诊断标准再探讨[J].2020,53(9).
[28]Forton Fabienne M. N..The Pathogenic Role of Demodex Mites in Rosacea: A Potential Therapeutic Target Already in Erythematotelangiectatic Rosacea?[J].2020,10(6).
[29]Yuan, Xin,Li, Ji,Li, Yangfan,etc.Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea[J].2019,117(117).
[30]Mohamed Essam‐Elden M.,Mohamed Tawfik Khaled,Hassan Ahmad Wafaa.Successful treatment of facial vascular skin diseases with a 577‐nm pro‐yellow laser[J].2019,18(6).
[31]Hoover, Rebecca M.,Erramouspe, John.Role of Topical Oxymetazoline for Management of Erythematotelangiectatic Rosacea[J].2018,52(3).
[32]Alexis,Kelly,Alexander,Pai,Ben,Lertsakdadet,etc.Microvascular Effects of Pulsed Dye Laser in Combination With Oxymetazoline.[J].2020,52(1).
[33]宋维芳,王素环,林炳基,等.DPL联合0.1%他克莫司软膏治疗红斑毛细血管扩张型玫瑰痤疮的临床观察[J].2020,(3).